CD36 and atherosclerosis: In this study, we aimed to develop a novel imaging platform for atherosclerotic plaque by constructing a molecular imaging probe that targets the lipid necrotic core using fluorescent molecules to identify high-risk plaque, based on the CD36 distribution in atherosclerosis.